XORTX Therapeutics Inc. filed a Form 6-K with the SEC reporting for October 2025, and it was signed by CEO Allen Davidoff on October 17, 2025. This filing does not report any specific events or quantitative data from prior dates but confirms the filing status under the Securities Exchange Act.